Arbutus Biopharma (ABUS) Profit After Tax Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) Profit After Tax Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | Arbutus Biopharma | 867.11 Mn | 771.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.35% |
| Dec 31, 2025 | 26.10% |
| Sep 30, 2025 | 16.24% |
| Jun 30, 2025 | 16.86% |
| Mar 31, 2025 | -12.12% |
| Dec 31, 2024 | 12.66% |
| Sep 30, 2024 | 24.89% |
| Jun 30, 2024 | 3.22% |
| Mar 31, 2024 | 5.12% |
| Dec 31, 2023 | -1.14% |
| Sep 30, 2023 | 3.86% |
| Jun 30, 2023 | -49.75% |
| Mar 31, 2023 | 1.28% |
| Dec 31, 2022 | 9.83% |
| Sep 30, 2022 | -9.75% |
| Jun 30, 2022 | 4.91% |
| Mar 31, 2022 | 3.28% |
| Dec 31, 2021 | 37.14% |
| Sep 30, 2021 | 0.42% |
| Jun 30, 2021 | 31.65% |